SCIENTURE HOLDINGS, INC. Proceeds from Contributed Capital
SCIENTURE HOLDINGS, INC. (SCNX) reported Proceeds from Contributed Capital of $1.50 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromContributedCapital · last filed 2023-03-27
- SCIENTURE HOLDINGS, INC. proceeds from contributed capital for fiscal 2022 was $1.50M.
| Period end | Proceeds from Contributed Capital 12 month |
|---|---|
| 2022-12-31 | $1.50M 10-K · filed 2023-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |